2009 Annual Report - CRH

More documents

Recommendations

Info

Report on Directors’ Remuneration continued Options by Price € 58 CRH 31st December 2008* Granted in 2009 Lapsed in 2009 Exercised in 2009 31st December 2009 13.2155 48,698 - - 48,698 - (a) 13.2155 97,397 - - 97,397 - (b) Earliest exercise date Expiry date 15.5646 121,746 - - - 121,746 (a) March 2010 April 2010 15.5646 82,715 - - 18,262 64,453 (b) March 2010 April 2010 16.2381 97,397 - - 97,397 - (a) 16.2381 79,135 - - 60,873 18,262 (b) March 2010 April 2010 16.4830 166,350 - - - 166,350 (c) March 2010 April 2011 16.4830 239,544 - - - 239,544 (d) March 2010 April 2011 17.7454 138,625 - - - 138,625 (c) March 2010 April 2012 17.7454 191,857 - - - 191,857 (d) March 2010 April 2012 11.8573 110,900 - - - 110,900 (c) March 2010 April 2013 11.8573 60,995 - - - 60,995 (d) March 2010 April 2013 11.9565 44,360 - - - 44,360 (c) March 2010 April 2013 11.9565 72,085 - - - 72,085 (d) March 2010 April 2013 15.0674 66,540 - - - 66,540 (c) March 2010 April 2014 15.0674 55,450 - - - 55,450 (d) April 2014 15.0854 44,360 - - - 44,360 (c) March 2010 April 2014 15.0854 72,085 - - - 72,085 (d) April 2014 18.7463 72,085 - - - 72,085 (c) March 2010 April 2015 18.8545 44,360 - - - 44,360 (c) March 2010 April 2015 26.1493 108,128 - - - 108,128 (c) April 2016 22.3892 221,800 - - - 221,800 (c) June 2016 29.4855 66,540 - - - 66,540 (c) April 2017 29.8643 58,223 - - - 58,223 (c) April 2017 21.5235 146,943 - - - 146,943 (c) April 2018 16.5800 - 130,000 - - 130,000 (c) April 2019 17.3000 - 35,000 - - 35,000 (c) April 2019 18.3946 3,504 - - - 3,504 (e) July 2013 December 2013 2,511,822 165,000 - 322,627 2,354,195 The market price of the Company’s shares at 31st December 2009 was €19.01 and the range during 2009 was €12.55 to €20.70. (a) Granted under the 1990 share option scheme, these options are only exercisable when earnings per share (EPS) growth exceeds the growth of the Irish Consumer Price Index over a period of at least three years subsequent to the granting of the options. (b) Granted under the 1990 share option scheme, these options are only exercisable if, over a period of at least five years subsequent to the granting of the options, the growth in EPS would place the Company in the top 25% of the companies listed in the FTSE 100 Stock Exchange Equity Index. (c) Granted under the 2000 share option scheme, these options are only exercisable when EPS growth exceeds the growth of the Irish Consumer Price Index by 5% compounded over a period of at least three years subsequent to the granting of the options. (d) Granted under the 2000 share option scheme, these options are only exercisable if, over a period of at least five years subsequent to the granting of the options, the growth in EPS exceeds the growth of the Irish Consumer Price Index by 10% compounded and places the Company in the top 25% of EPS performance of a peer group of international building materials and other manufacturing companies. If below the 75th percentile, these options are not exercisable. (e) Granted under the 2000 savings-related share option scheme.
Directors’ Interests in Share Capital at 31st December 2009 The interests of the Directors and the Secretary in the shares of the Company as at 31st December 2009, which are beneficial unless otherwise indicated, are shown below. The Directors and the Secretary have no beneficial interests in any of the Group’s subsidiary, joint venture or associated undertakings. Ordinary Shares 31st December 2009 31st December 2008 Directors G.A. Culpepper 32,180 19,170 * W.P. Egan 16,427 15,000 - Non-beneficial 12,000 12,000 U-H. Felcht 1,285 1,000 N. Hartery 1,285 1,000 J.M. de Jong 13,502 10,190 J.W. Kennedy 1,009 * - M. Lee 323,027 ** 258,246 ** K. McGowan 21,344 16,167 A. Manifold 11,790 5,742 * T.V. Neill 89,844 69,881 D.N. O’Connor 15,040 11,478 J.M.C. O’Connor 2,763 2,131 W.I. O’Mahony 1,089,431 827,821 ** M.S. Towe 34,420 18,857 Secretary N. Colgan 10,527 10,434 * 1,675,874 1,279,117 There were no transactions in the above Directors’ and Secretary’s interests between 31st December 2009 and 1st March 2010. Of the above holdings, the following are held in the form of American Depositary Receipts (ADRs): 31st December 2009 31st December 2008 G.A. Culpepper 179 179 * W.P. Egan 10,000 10,000 - Non-beneficial 12,000 12,000 M.S. Towe 3,397 3,397 * Holding as at date of appointment. ** Excludes awards of Deferred Shares, details of which are shown on page 55. CRH 59
Page 1 and 2:
Annual Report 2009 PERFORMANCE AND
Page 3 and 4:
Contents inside cover CRH at a Glan
Page 5 and 6:
Key Financial Figures 2009 €m 2,8
Page 7 and 8:
Americas Materials - 37% of Group T
Page 9 and 10:
CRH is an international group with
Page 11 and 12: . . Emerging Regions - Strategy in
Page 13 and 14: . . . . . . Diverse Portfolio - Str
Page 15 and 16: CRH is committed to ethically and r
Page 17 and 18: as well as adding to our presence i
Page 19 and 20: Chief Executive’s Review Overview
Page 21 and 22: Responding to the evolving market e
Page 23 and 24: Group Operations The global economi
Page 25 and 26: Europe Materials Europe Materials e
Page 27 and 28: operating adjustments were implemen
Page 29 and 30: Europe Products & Distribution Thro
Page 31 and 32: Building Envelope Products These op
Page 33 and 34: Mark Towe Chief Executive Officer T
Page 35 and 36: asphalt plants and paving operation
Page 37 and 38: Mark Towe Chief Executive Officer T
Page 39 and 40: Glass The Glass group is the market
Page 41 and 42: offset by the decline in the averag
Page 43 and 44: which mature after more than one ye
Page 45 and 46: W.I. O’Mahony* BE, BL, MBA, FIEI
Page 47 and 48: issues confronting the Group; that
Page 49 and 50: # assists management, at their requ
Page 51 and 52: accounting period and up to the dat
Page 53 and 54: # CRH’s business may be affected
Page 55 and 56: Report on Directors’ Remuneration
Page 57 and 58: Directors’ Remuneration Notes Exe
Page 59 and 60: Pension entitlements - defined bene
Page 61: Directors’ interests The Company
Page 65 and 66: Independent Auditors’ Report to t
Page 67 and 68: Consolidated Balance Sheet as at 31
Page 69 and 70: Consolidated Statement of Cash Flow
Page 71 and 72: the Group and one or more other ven
Page 73 and 74: indicate that the carrying values m
Page 75 and 76: floating rates (using interest rate
Page 77 and 78: 1. Segment Information continued A.
Page 79 and 80: 2. Proportionate Consolidation of J
Page 81 and 82: 5. Directors’ Emoluments and Inte
Page 83 and 84: 7. Share-based Payment Expense cont
Page 85 and 86: 8. Finance Costs and Finance Revenu
Page 87 and 88: 10. Income Tax Expense continued Fa
Page 89 and 90: 13. Property, Plant and Equipment L
Page 91 and 92: 14. Intangible Assets continued Goo
Page 93 and 94: 17. Inventories 2009 2008 €m €m
Page 95 and 96: 21. Capital and Financial Risk Mana
Page 97 and 98: 21. Capital and Financial Risk Mana
Page 99 and 100: 23. Interest-bearing Loans and Borr
Page 101 and 102: 24. Derivative Financial Instrument
Page 103 and 104: 25. Analysis of Net Debt Components
Page 105 and 106: 25. Analysis of Net Debt continued
Page 107 and 108: 27. Deferred Income Tax The deducti
Page 109 and 110: 28. Retirement Benefit Obligations
Page 111 and 112: 28. Retirement Benefit Obligations
Page 113 and 114:
29. Capital Grants 2009 2008 €m
Page 115 and 116:
30. Share Capital and Reserves cont
Page 117 and 118:
32. Acquisition of Subsidiaries and
Page 119 and 120:
33. Related Party Transactions The
Page 121 and 122:
Notes to the Company Balance Sheet
Page 123 and 124:
7. Movement in Shareholders’ Fund
Page 125 and 126:
CREST Transfer of the Company’s s
Page 127 and 128:
John Parson President & Chief Opera
Page 129 and 130:
Incorporated and operating in % hel
Page 131 and 132:
Incorporated and operating in % hel
Page 133 and 134:
Principal Joint Venture Undertaking
Page 135 and 136:
Group Financial Summary (Figures pr
Page 137 and 138:
G Geographic leadership positions 2
Page 139 and 140:
Notes
show all

2009 Annual Report - CRH

Create successful ePaper yourself

Delete template?

Save as template?